Pharmacist Society

06/11/2013 - 12:08pm
Study: Medicare Part D sources 2 to 3 times more branded Rx than VA

The Annals of Internal Medicine published a study comparing generic utilization of common diabetes medications across two government programs — Medicare Part D and the U.S. Department of Veterans Affairs.

06/11/2013 - 11:47am
CVS Caremark receives URAC accreditation in specialty pharmacy

CVS Caremark announced on Tuesday that it has been awarded Specialty Pharmacy accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization that establishes quality standards for the healthcare industry.

06/11/2013 - 11:43am
Rising Pharmaceuticals to launch authorized generic of Lou Gehrig's disease drug

Aceto Corp. will sell an authorized generic version of a drug used to treat a rare but devastating degenerative disorder.

06/11/2013 - 10:25am
Fruth Pharmacy launches mobile app

Fruth Pharmacy has launched a new mobile app and mobile website, the retail pharmacy chain said.

06/10/2013 - 3:00pm
Study supports low-calorie sweeteners as way to help prevent, manage diabetes

Low-calorie sweeteners can be used to prevent and manage Type 2 diabetes, according to a new study.

06/10/2013 - 2:25pm
Concern about birth defects shouldn't stop women from taking mental health drugs, experts say

Pregnant women taking drugs for mental health problems should not stop taking their drugs without first talking to their doctors, experts say.

06/10/2013 - 2:14pm
Amag licenses cancer-treatment side effect drug for $3.3 million

Drug maker Amag Pharmaceuticals has licensed the U.S. commercial rights to a treatment for a common side effect of cancer treatments from another company, Amag said Monday.

06/10/2013 - 1:56pm
Specialty Pharmacy Certification Board appoints CSPN, Diplomat, AxelaCare executives to board

The Specialty Pharmacy Certification Board has appointed three new members to its board of directors, the group said Monday.

06/10/2013 - 11:07am
AstraZeneca to buy developer of COPD drug

Anglo-Swedish drug maker AstraZeneca will pay up to $1.15 billion for a U.S. developer of drugs for respiratory diseases, AstraZeneca said Monday.

06/10/2013 - 10:33am
Giant-Carlisle sponsors diabetes fair

Free health screenings, a weight-bearing exercise and other activities will be featured at an upcoming diabetes fair sponsored by Giant Food Stores, the supermarket chain said.

© 2013 Drug Store News. All Rights Reserved.